4//SEC Filing
OMEGA PROTEIN CORP 4
Accession 0001209191-16-141135
CIK 0001053650operating
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:10 PM ET
Size
9.2 KB
Accession
0001209191-16-141135
Insider Transaction Report
Form 4
Griffin Mark Edward
VP - Research and Development
Transactions
- Exercise/Conversion
Common Stock
2016-09-12$7.07/sh+75,000$530,250→ 149,891 total - Sale
Common Stock
2016-09-12$25.12/sh−75,000$1,884,000→ 74,891 total - Exercise/Conversion
Stock Option (right to buy)
2016-09-12−75,000→ 0 totalExercise: $7.07From: 2011-12-01Exp: 2020-12-01→ Common Stock (75,000 underlying)
Footnotes (4)
- [F1]Stock Option exercised and shares sold automatically pursuant to Trading Plan (SEC Rule 10b5-1)
- [F2]Value represents transactions with a weighted average sales price ranging from $24.89 to $25.51.
- [F3]Full information regarding the number of shares purchased or sold at each separate price will be provided by the filer to the Commission staff, the issuer, or a security holder of the issuer upon request.
- [F4]Vests in 1/3 increments commencing on the first anniversary of date of grant. The date of grant was 12/01/2010.
Documents
Issuer
OMEGA PROTEIN CORP
CIK 0001053650
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001053650
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:10 PM ET
- Size
- 9.2 KB